Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2008
08/28/2008WO2008074833A3 Compounds
08/28/2008WO2008033851A3 Use of 2-6- (3-amino-piperidin-l-yl) -3-methyl-2, 4-dioxo-3, 4-dihydr0-2h-pyrimidin-1-ylmet hyl-4-fluoro-benzonitrile
08/28/2008WO2008019823A3 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins
08/28/2008WO2007112069A3 Endothelin and endothelin receptor agonists in the treatment of metabolic diseases
08/28/2008US20080207758 Reaction product of rhein with bases or amino acids; antidiabetic agents; gastrointestinal disorders; antiarthritic agents
08/28/2008US20080207757 Polar Hydrophilic Prodrugs of Amphetamine and Other Stimulants and Processes for Making and Using the Same
08/28/2008US20080207747 Lipase Inhibitors
08/28/2008US20080207735 1-Amino Linked Compounds
08/28/2008US20080207724 Use of Inhibitors of Histone Deacteylases in Combination With Compounds Acting as Nsaid for the Therapy of Human Diseases
08/28/2008US20080207717 Composition to provide maintenance and nutritional support in glycemic control deficits
08/28/2008US20080207716 Formulations and Dosing Regiment for Ppar-Alpha Modulators
08/28/2008US20080207707 Aryl-substituted heterocycles, process for their preparation and their use as medicaments
08/28/2008US20080207705 Heteroaryl-Imidazole Derivatives as Cannabinoid CB1 Receptor Antagonists
08/28/2008US20080207702 Use of Quaternary Pyridinium Salts as Vasoprotective Agents
08/28/2008US20080207701 Opioid receptor antagonists
08/28/2008US20080207700 Amino Acid Salts of Rosiglitazone
08/28/2008US20080207691 Metabolic disorders; antidiabetic agents; hypoglycemic agents; obesity; hypotensive agents
08/28/2008US20080207685 Heterocyclic Compounds As Modulators Of Peroxisome Proliferator Activated Receptors, Useful For The Treatment And/Or Prevention Of Disorders Modulated By A Ppar
08/28/2008US20080207680 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
08/28/2008US20080207671 Using inhibitors of target of rapamycin (TOR) gene products as therapeutic agent in treatment of diabetic vision defects
08/28/2008US20080207654 Therapy for circulatory diseases; metabolism disorders; central nervous system disorders; hypotensive agents; cardiovascular disorders; antidiabetic agents; Alzheimer's disease
08/28/2008US20080207643 Composition for Treating Hyperlipaemia
08/28/2008US20080207642 Respiratory system disorders; asthma; chronic obstructive pulmonary diseases; autoimmune diseases; antiproliferative agents; anticancer agents
08/28/2008US20080207637 Controlling triglyceride concentration; central nervous system disorders; psychological disorders; eating disordes; drug abuse; anticancer agents
08/28/2008US20080207636 Using a benzmide compound; antidiabetic agents; obesity
08/28/2008US20080207635 Tyrosine kinase moderators; anticancer agents; antidiabetic agents; restenosis; arteriosclerosis ; skin disorders;
08/28/2008US20080207624 Therapeutic Agent for Bh4-Responsive Hyperphenylalaninemia
08/28/2008US20080207614 Quinazoline derivatives for the treatment and prevention of diabetes and obesity
08/28/2008US20080207611 Anticancer agents; kinase inhibitors; viricides; antiinflammatory agents; immunotherapy; metabolism disorders
08/28/2008US20080207594 Glycogen synthase kinase inhibitor in mixture with immunomodulating agents; antidiabetic agents; immunosupprsants
08/28/2008US20080207592 Novel 1,4-benzothiazepine-1,1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof
08/28/2008US20080207587 Pyridazine Derivatives for Inhibiting Human Stearoyl-Coa-Desaturase
08/28/2008US20080207585 Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof
08/28/2008US20080207584 Compound Having S1P Receptor Binding Potency and Use Thereof
08/28/2008US20080207534 1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic
08/28/2008US20080207526 Synthetic peptides and methods of use for autoimmune disease therapies
08/28/2008US20080207514 Drug delivery agents of N-([2-hydroxybenzoyl- or 2-hydroxynaphthoyl]-amino)alkanoic acid derivatives or salts; phenoxyalkanoic acid or salts; increased bioavailability; hyperglycemic agents
08/28/2008US20080207512 Methods for Treating Obesity and Obesity Related and Disorders
08/28/2008US20080207507 Hypoglycemic agents; antidiabetic agents ; hypotensive agents; cardiovascular disorders; strokes; antiinflammatory agents; antiulcer agents; glucangon-like peptide
08/28/2008US20080207501 Therapy for metabolism disorders, cardiovascular disorders, obesity, antidiabetic agents
08/28/2008US20080207493 Moderator of melanocortin receptor ; delay diabetes
08/28/2008US20080207490 Glucose Uptake Modulator and Method for Treating Diabetes or Diabetic Complications
08/28/2008US20080206377 Topical Compositions and Methods For Alleviating or Inhibiting Symptoms Associated With Carpal Tunnel Syndrome, Acid Reflux, Psoriasis, Cartilage Nodules, Fibromyalgia, and Diabetes
08/28/2008US20080206372 A mixture of two plant extracts from Syzygium cumini and Bauhinia forficata obtained by pulverizing the seeds and leaves, homogenizing and encapsulating; hypoglycemic agents for non-insulin dependent diabetics
08/28/2008US20080206367 Regulating gastric motility and regulating plasma levels of cholecystokinin; grape juice, blueberry juice, quercetin and rutin
08/28/2008US20080206342 Compositions and Methods For Increasing the Bioavailability of Pulmonarily Administered Insulin
08/28/2008US20080206340 Galactomannans and/or Glucomannans For Increasing the Bioavailability of Active Substances
08/28/2008US20080206339 Very-pure superporous hydrogels having outstanding swelling properties
08/28/2008US20080206336 Once-a-day modified release tablet formulation rosiglitazone and metformin; enteric coating to control the rate of release; erosion of coating under pre-determined pH conditions; diabetes mellitus, metabolic syndrome, impaired glucose tolerance or impaired fasting glucose
08/28/2008US20080206327 Phentermine weight-loss drug; excipients, bulking agents, binders, disintegrating agents, acidifying agents, sweetening agents, lubricants, flavorings; child, adolesent obesity
08/28/2008US20080206316 Nutraceutical; chromium atoms bonded to fatty acids; linoleic acid, linolenic acid, gamma-linolenic acid, arachidonic acid; and transition metal, an alkaline metal, alkaline earth metal, rare earth metal, or metalloid; nutritional supplements, food stuffs, and pharmaceutical compositions
08/28/2008US20080206313 Nutraceutical; vitamin B, amine oxidase enzyme inhibitor of semicarbazide-sensitive amine oxidases; additive to a foodstuff or as a dietary supplement; atherosclerosis, vascular retinopathies, retinopathy, glomerulosclerosis, nephropathy, nephrotic syndrome, polyneuropathy, mononeuropathies
08/28/2008US20080206267 Inactivation Of Genes Of The Mep Pathway
08/28/2008US20080206266 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules
08/28/2008US20080206232 Compositions and Methods For Modulating Pgc-1Beta to Treat Lipid-Related Diseases and Disorders
08/28/2008US20080206223 Treatment of pompe's disease
08/28/2008US20080206162 Composition and Methods for Treating Alzheimer's Disease and Other Amyloidoses
08/28/2008DE112006002618T5 Verfahren und Zusammensetzungen zum selektiven Entfernen von Kaliumionen aus dem Gastrointestinaltrakt eines Säugers Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
08/28/2008DE102007008420A1 Benzimidazolderivate Benzimidazole derivatives
08/28/2008DE10164893B4 Verfahren zur Herstellung von Artischockenblätterextrakten und so erhaltene Artischockenblätterextrakte Process for the preparation of artichoke leaf extracts and extracts so obtained artichoke leaves
08/28/2008CA2678846A1 Peroxisome proliferator activated receptor modulators
08/28/2008CA2678757A1 Ameliorating agent for insulin resistance
08/28/2008CA2678687A1 Benzimidazole derivatives
08/28/2008CA2677706A1 Compounds and methods for modulating g protein-coupled receptors
08/28/2008CA2677705A1 Thiazole derivatives as modulators of g protein-coupled receptors
08/27/2008EP1961816A1 Novel highly functional enzyme having modified substrate-specificity
08/27/2008EP1961768A1 Recombinant IL-18 Antibodies useful in Treatment of IL-18 mediated Disorders
08/27/2008EP1961764A1 Sugar chain adduct of peptide and pharmaceutical comprising the same as active ingredient
08/27/2008EP1961748A2 2-hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors
08/27/2008EP1961312A2 Microbial oil mixture and uses thereof
08/27/2008EP1961309A1 Equal-containing fermentation product of soybean embryonic axis, and method for production thereof
08/27/2008EP1960436A1 Chitin derivatives for hyperlipidemia
08/27/2008EP1960401A1 Tricyclic amide derivatives useful for treating obesity
08/27/2008EP1960391A1 Piperazine derivatives and their use in therapy
08/27/2008EP1960387A1 Isoquinoline et benzo[h]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine h3 receptor
08/27/2008EP1960386A2 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
08/27/2008EP1960385A1 Substituted dihydroisoindolones as allosteric modulators of glucokinase
08/27/2008EP1960377A1 l , l , 3-TRI0X0-l , 2 , 5-THIADIAZ0LIDINES AND THEIR USE AS PTP-ASES INHIBITORS
08/27/2008EP1960359A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions
08/27/2008EP1960356A2 Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors
08/27/2008EP1959987A2 Mucosal delivery of stabilized formulations of exendin
08/27/2008EP1959951A1 Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors
08/27/2008EP1959945A1 Method for correcting a lipid imbalance in a subject
08/27/2008EP1959763A1 High-potency sweetener composition with phytosterol and compositions sweetened therewith
08/27/2008EP1959760A1 High-potency sweetener for weight management and compositions sweetened therewith
08/27/2008EP1959755A1 High-potency sweetener composition with c-reactive protein reducing substance and compositions sweetened therewith
08/27/2008EP1905763A4 N-acylic aminoacid derivatives. method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents
08/27/2008EP1644368B1 Indolyl derivatives substituted with a thiazole ring and their use as ppar modulators
08/27/2008EP1601668B1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
08/27/2008EP1408981B1 Methods for preventing antipsychotic-induced weight gain
08/27/2008EP1392284B1 Methods of treating hyperlipidemia
08/27/2008EP1355942B1 Glp-1 fusion proteins
08/27/2008EP1337560B1 Truncated cd200
08/27/2008EP1313714B1 Valsartan salts
08/27/2008EP1234025B1 Human enzymes of the metalloprotease family
08/27/2008EP1228086B1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES
08/27/2008EP1090026B1 Diacylglycerol o-acyltransferase
08/27/2008CN101253171A Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives
08/27/2008CN101253155A 11-beta-hydroxysteroid dehydrogenase-1-inhibitor-diabetes-type 2-1
08/27/2008CN101253153A 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d] azepines as 5-HT2c receptor agonists
1 ... 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 ... 1298